Treatment outcomes of mucosal melanoma of head and neck: Efficacy of immune checkpoint inhibitors for advanced disease

BACKGROUND: Head and neck mucosal melanoma (HNMM) is a rare and aggressive subtype of melanoma. HNMM often develops as a recurrent or metastatic disease, and its prognosis is worse than that of cutaneous melanoma. Recent large-scale clinical studies have reported favorable outcomes with immune check...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohshima, Shusuke, Ueki, Yushi, Yokoyama, Yusuke, Takahashi, Takeshi, Shodo, Ryusuke, Yamazaki, Keisuke, Okabe, Ryuichi, Matsuyama, Hiroshi, Togashi, Takafumi, Takatsuka, Sumiko, Takenouchi, Tatsuya, Horii, Arata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112385/
https://www.ncbi.nlm.nih.gov/pubmed/37082097
http://dx.doi.org/10.3389/fsurg.2022.1032626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112385/
https://www.ncbi.nlm.nih.gov/pubmed/37082097
http://dx.doi.org/10.3389/fsurg.2022.1032626

Ejemplares similares